| |
 |
|
Class Information
Number: 435/344
Name: Chemistry: molecular biology and microbiology > Animal cell, per se (e.g., cell lines, etc.); composition thereof; process of propagating, maintaining or preserving an animal cell or composition thereof; process of isolating or separating an animal cell or composition thereof; process of preparing a composition containing an animal cell; culture media therefore > Animal cell, per se, expressing immunoglobulin, antibody, or fragment thereof > Immunoglobulin or antibody binds a microorganism or normal or mutant component or product thereof (e.g., animal cell, cell surface antigen, secretory product, etc.) > Binds a cancer cell or component or product thereof (e.g., cell surface antigen, etc.)
Description: Subject matter involving an animal cell which produces a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with an integral or isolated part of a cancer cell, or with a substance shed or secreted by a cancer cell.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7449340 |
Method for the early diagnosis of cancer |
Nov. 11, 2008 |
| 7445780 |
Antagonistic anti-CD40 antibodies |
Nov. 4, 2008 |
| 7381560 |
Expression and use of anti-CD20 antibodies |
Jun. 3, 2008 |
| 7374765 |
Methods and compositions for diagnosis and treatment of iron misregulation diseases |
May. 20, 2008 |
| 7374936 |
Method and means for site directed therapy |
May. 20, 2008 |
| 7276372 |
Antibodies against GPR64 and uses thereof |
Oct. 2, 2007 |
| 7264965 |
Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means |
Sep. 4, 2007 |
| RE39760 |
Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor |
Aug. 7, 2007 |
| 7252994 |
Human DR4 antibodies and uses thereof |
Aug. 7, 2007 |
| 7244429 |
Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
Jul. 17, 2007 |
| 7163797 |
50 human secreted proteins |
Jan. 16, 2007 |
| 7148038 |
Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof |
Dec. 12, 2006 |
| 7087727 |
Periostin-based diagnostic assays |
Aug. 8, 2006 |
| 7070995 |
CE7-specific redirected immune cells |
Jul. 4, 2006 |
| 6984382 |
Bifunctional protein, preparation and use |
Jan. 10, 2006 |
| 6924359 |
Neovascular-targeted immunoconjugates |
Aug. 2, 2005 |
| 6884418 |
Use of ligand-mimicking agents and anti-neoplastic drugs in cancer therapy |
Apr. 26, 2005 |
| 6872568 |
Death domain containing receptor 5 antibodies |
Mar. 29, 2005 |
| 6861511 |
Detection and quantification of neu related proteins in the biological fluids of humans |
Mar. 1, 2005 |
| 6855508 |
ELISA for VEGF |
Feb. 15, 2005 |
| 6770745 |
Common gamma chain blocking agents |
Aug. 3, 2004 |
| 6743898 |
Monoclonal antibodies that suppress B cell growth and/or differentiation |
Jun. 1, 2004 |
| 6632620 |
Compositions for identification and isolation of stem cells |
Oct. 14, 2003 |
| 6613538 |
Detection of HLA-G |
Sep. 2, 2003 |
| 6541253 |
Diagnostics and therapy of diseases associated with HHV-8 infections |
Apr. 1, 2003 |
| 6482614 |
Stress proteins and uses therefor |
Nov. 19, 2002 |
| 6479241 |
High throughput screening of the effects of anti-cancer agents on expression of cancer related genes in various cell lines |
Nov. 12, 2002 |
| 6447776 |
Mutations of E cadherin as a basis for the diagnosis and therapy of human malignant tumors |
Sep. 10, 2002 |
| 6440733 |
Monoclonal antibodies recognizing antigens on the surface of endothelial cells of tumor vessel |
Aug. 27, 2002 |
| 6410319 |
CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies |
Jun. 25, 2002 |
| 6376654 |
Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof |
Apr. 23, 2002 |
| 6322787 |
Induction of an anti-tumor immunity by redirecting tumor cells against antigen-presenting cells |
Nov. 27, 2001 |
| 6306575 |
Methods for preparing enriched human hematopoietic cell preparations |
Oct. 23, 2001 |
| 6306615 |
Detection method for monitoring .beta. tubulin isotype specific modification |
Oct. 23, 2001 |
| 6294172 |
Monoclonal antibodies with specificity for membrane-associated antigens |
Sep. 25, 2001 |
| 6258939 |
PSCA antibodies and hybridomas producing them |
Jul. 10, 2001 |
| 6245898 |
Monoclonal antibodies that recognize antigens associated with tumor metastasis |
Jun. 12, 2001 |
| 6200763 |
Myeloid cell leukemia associated gene mcl-1 |
Mar. 13, 2001 |
| 6201107 |
Cystic fibrosis gene |
Mar. 13, 2001 |
| 6174726 |
Method for the immortalization of cells using conditionally transformed helper cells |
Jan. 16, 2001 |
| 6162902 |
Human BNP-specific antibodies |
Dec. 19, 2000 |
| 6159751 |
Development of DNA probes and immunological reagents of human tumor associated antigens |
Dec. 12, 2000 |
| 6156307 |
Immortalization of dendritic cells with v-myc oncogene |
Dec. 5, 2000 |
| 6150116 |
Transcription factor DP-1 antibody |
Nov. 21, 2000 |
| 6143873 |
Monoclonal anti-multiple drug resistance antibody, methods of production and uses thereof |
Nov. 7, 2000 |
| 6139869 |
Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
Oct. 31, 2000 |
| 6106833 |
Bispecific antibodies, methods of production and use thereof |
Aug. 22, 2000 |
| 6107090 |
Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains |
Aug. 22, 2000 |
| 6090924 |
Human-Human CLNH5-specific antibodies |
Jul. 18, 2000 |
| 6075127 |
Preparation of purified (poly)peptides |
Jun. 13, 2000 |
|
|
|
